Trials / Completed
CompletedNCT02793635
Indego Exoskeleton After SCI
Impact of Gait Training With an Exoskeleton on Walking Function After Spinal Cord Injury (SCI)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Parker Hannifin Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the use of Indego as a gait training tool for subjects with complete or incomplete paraplegia as a result of spinal cord injury (SCI) who have preserved lower extremity function. It is hypothesized that subjects with complete or incomplete paraplegia who have preserved their lower extremity function will experience functional improvements after gait training with the Indego exoskeleton. Subjects will complete a total of fifteen (15) sessions which include a combination of the following; Physical Therapy Evaluation, Indego Training, Mid-Way Assessment, and Post-Assessment. The aim of this study is to measure the impact of gait training with the Indego device on body structure, function, and participation. Additionally it will assess the perceptions of physical therapists and subjects with SCI on the effectiveness of gait training with the Indego exoskeleton in subjects with preserved limited function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Indego Powered Exoskeleton | Subjects who have Spinal Cord Injury will wear the Indego device which will include being trained and evaluated for fifteen (15) sessions. |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2016-06-08
- Last updated
- 2018-08-31
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02793635. Inclusion in this directory is not an endorsement.